Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01187810Phase 1Terminated
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkin's Lymphoma
Studychair

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Barry J Maurer, MD, PhD

Texas Tech University Health Sciences Center

Moderately Similar
2 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Min Kang, PharmD

Texas Tech University Health Sciences Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Patrick Reynolds, MD, PhD

Texas Tech University Health Sciences Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Shengping Yang, PhD

Texas Tech University Health Sciences Center

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin

Worked with same sponsors:

South Plains Oncology Consortium
Collaborated on 1 trial
Similarity Score34%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin
Similarity Score30%

Yves Beguin, MD, PhD

CHU-ULg

Moderately Similar
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin
Similarity Score30%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score20%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01187810Phase 1StudyChair

Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkin's Lymphoma
Terminated

All 1 trials loaded